Associate Director, Start-up Lead, SiteID & Activation

The businesses of Merck KGaA, Darmstadt, Germany•Billerica, MA
•$128,700 - $193,000

About The Position

We are seeking an experienced clinical research professional to serve as the Associate Director, Start-up Lead, SiteID & Activation to lead start-up and site activation strategies across our global clinical trial portfolio. This role is crucial in driving operational excellence to bring medicines to patients faster and ensuring compliance with ICH-GCP standards and applicable regulations.

Requirements

  • Medical or Life Sciences degree or equivalent qualification
  • 10+ years in clinical research in a CRO or Pharmaceutical / Biotechnology Industry environment
  • 5 years of project management and experience in study start-up activities
  • Thorough knowledge of ICH-GCP and applicable laws and regulations for key countries

Nice To Haves

  • PM certification (CPM, PMP)
  • Strong communication skills - verbal, written and listening
  • Fail fast and data driven mentality as well as agile methodology
  • Strong data insights and analytical skills to identify trends and drive quality / process improvements
  • Ability to balance competing priorities of various stakeholders and strive for achieving mutually beneficial and compliant solutions
  • Experience in multiple Therapeutic Areas, especially in oncology

Responsibilities

  • Oversee country and site feasibility assessments
  • Drive regulatory submissions and site activations from protocol through implementation
  • Collaborate with internal teams and external service providers to accelerate study timelines and optimize recruitment outcomes
  • Champion process improvements
  • Manage performance metrics
  • Drive operational excellence to bring medicines to patients faster
  • Ensure compliance with ICH-GCP standards and applicable regulations

Benefits

  • health insurance
  • paid time off (PTO)
  • retirement contributions
  • other perquisites
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service